Clinical Trials

Showing 361 - 380 of 513 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041]
Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Nivolumab plus Ipilimumab versus Sunitinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma
[Protocol 14-199]
Motzer, Robert
  • Kidney Cancer
A Phase III Study of Nivolumab versus Standard Chemotherapy as Initial Treatment for Metastatic or Recurrent Non-Small Cell Lung Cancers that Express PD-L1
[Protocol 14-095]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase III Study of Olaparib versus Standard Chemotherapy to Treat Patients with Metastatic Breast Cancer Who Have BRCA Mutations
[Protocol 14-157]
Robson, Mark
  • Breast Cancer
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081]
Lee, Nancy
  • Head & Neck Cancer
A Phase III Study of Preoperative Radiotherapy plus Surgery versus Surgery Alone for Patients with Retroperitoneal Sarcoma
[Protocol 14-051]
Crago, Aimee
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Radioactive Iodine with and without Selumetinib in Patients with High-Risk Thyroid Cancer After Thyroidectomy
[Protocol 13-133]
Ho, Alan
  • Thyroid Cancer
A Phase III Study of Rituximab plus Ibrutinib or Placebo in Patients with Persistent Waldenstrom's Macroglobulinemia
[Protocol 14-257]
Palomba, M. Lia
  • Hematology
    • Hematologic Malignancies
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Rucaparib after Platinum-Based Chemotherapy in Women with High-Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 14-067]
Bell-McGuinn, Katherine
  • Ovarian Cancer
A Phase III Study of Sorafenib Alone versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Patients with Liver Cancer
[Protocol 13-250]
Goodman, Karyn
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Sorafenib plus Doxorubicin versus Sorafenib Alone in Patients with Advanced Hepatocellular Cancer
[Protocol 11-039]
Abou-Alfa, Ghassan
  • Hepatobiliary
    • Liver Cancer
A Phase III Study of Sorafenib versus Placebo in Patients with Desmoid Tumors
[Protocol 14-015]
Gounder, Mrinal
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Surgery Followed by Radiation Therapy or Observation in Patients with Neurotropic Melanoma of the Head and Neck
[Protocol 13-248]
Barker, Christopher
  • Melanoma
A Phase III Study of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
[Protocol 11-190]
Morrow, Monica
  • Breast Cancer
A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Pancreatic Cancer
[Protocol 10-083]
Goodman, Karyn
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IV Study of Enzalutamide in Men with Metastatic Prostate Cancer Who Are at Risk for Seizures
[Protocol 13-231]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Pilot Phase II Study of Targeted Radiotherapy with 131I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
[Protocol 04-148]
Basu, Ellen
  • Neuroblastoma
A Pilot Study Assessing Insulin Sensitivity and Diabetes Risk in Survivors of Childhood Cancer Who Were Treated with Abdominal Radiation
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-202]
Friedman, Danielle
  • Survivorship
A Pilot Study Assessing PET Probes to Detect Cancerous Tissue During Surgery for Recurrent Ovarian Cancer
[Protocol 13-017]
Chi, Dennis
  • Ovarian Cancer
A Pilot Study of a Breathing Training Exercise to Reduce Chronic Shortness of Breath
[Protocol 12-261]
Deng, Gary
  • Lung Cancer
  • Survivorship